- GLP-1s can cut the risk of Alzheimer’s. What does that mean for Novo Nordisk? Endpoints News
- Obesity drugs: huge study identifies new health risks Nature.com
- Weight-loss jabs linked to reduced risk of 42 conditions including dementia The Guardian
- Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds CNN
- Sweeping review suggests weight-loss drugs’ effect on 175 conditions The Washington Post